What is the current Price Target for the Forte Biosciences Inc stock?

The average Forte Biosciences Inc target price is $107.00. This is 565.42% higher than the current stock price. The highest price target is 832.84%, the lowest is 298.01%. 2 Analysts have issued a price target Forte Biosciences Inc 2025 .

How high will the Forte Biosciences Inc stock rise?

No reliable answer can be given as to how high the Forte Biosciences Inc stock will rise. The performance of stocks, including the Forte Biosciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Forte Biosciences Inc stock today?

The performance of Forte Biosciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Forte Biosciences Inc stock fall?

The decline in Forte Biosciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Forte Biosciences Inc Forecast, price target & analysts

$15.30

4.85% today

Nasdaq, Nov 26, 02:48 pm CET

ISIN

US34962G1094

Symbol

FBRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Forte Biosciences Inc Target price 2024 - Analyst rating & recommendation

Forte Biosciences Inc Classifications & Recommendation:

Buy

100%

Forte Biosciences Inc Price Target

Target Price	$107.00
Price	$16.08
Potential	565.42% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Forte Biosciences Inc 2025 . The average Forte Biosciences Inc target price is $107.00. This is 565.42% register free of charge higher than the current stock price. The highest price target is $150.00 832.84% register free of charge , the lowest is $64.00 298.01% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend Forte Biosciences Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Forte Biosciences Inc stock has an average upside potential 2025 of 565.42% register free of charge . Most analysts recommend the Forte Biosciences Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-24.92	-0.08
	3,015.00%	99.68%
P/E		negative

The average Forte Biosciences Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

2023	$-24.92	3,015.00%
2024	$-0.08 99.68% Unlock
2025	$-0.08 0.00% Unlock

Current	-0.83	130.56%
2024	-201.00 24,116.87% Unlock
2025	-201.00 0.00% Unlock

Forte Biosciences Inc...

Discover more stocks with a high price target

Valneva 284.61%

CureVac N.V. 145.33%

Moderna 70.75%

Bavarian Nordic 61.25%

Nel ASA 44.32%

Aixtron 43.84%

Volkswagen VZ 41.85%

Alibaba Group Holding Ltd 40.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now